It is increasing world-wide at an alarming rate in United States and in other industrialized countries, raising by more than 30% over last decade to afflict on average 33% of adults in United States, and 17% in UK and elsewhere including Poland (1)
In the UK, the NIHR 'Be Part of Research' service (bepartofresearch.nihr.ac.uk) is a helpful starting point for finding legitimate clinical trials
For now, any GLP-1 patch being sold is not a legitimate, tested, or safe pharmaceutical product
Why should a drug that makes you think less about food also reduce migraines and gambling compulsions and Parkinsons symptoms
Some patients taking GLP-1s can experience dizziness, especially if theyre not well-hydrated, McGee explains
Why the Change Is Happening Now The FDA announced that shortages of GLP-1s and tirzepatide are resolved as of April 2025, impacting compounded versionscustom-made options from pharmacies